New combo flu pill put to the test in healthy volunteers

This early-stage study tests a new combination capsule (Ingavirin Forte) that contains two active ingredients against the standard single-ingredient Ingavirin. The goal is to see how the body processes each version and whether the combination is safe. Thirty-six healthy adults will take both versions at different times, under fasting and fed conditions, so researchers can compare drug levels and side effects.